From particles to drug product performance and stability
March 21st 2023
Dr Daniel Markl from CMAC’s Digital Medicines Manufacturing research center (DM² ) co-hosted a webinar as part of a series run by the centre partner, Malvern Panalytical.
In this second webinar by DM², Daniel discussed the interplay between particle properties, formulation, microstructure and stability-related performance changes. He also provided insights into how these characteristics can be exploited to develop digitally driven design processes and how he and his team are doing this in their research for DM² Platform 2: Autonomous MicroScale Manufacturing.
